Search Browse Earnings

Nuvation Bio Inc. — SlamSEC

Nuvation Bio Inc.

NYSE:NUVB

Pharmaceutical Preparations·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$7.9M

FY 2025

Adj. EBITDA

-$591.9M

-7518.7% margin

FY 2025

Net Income

-$567.9M

-7213.8% margin

FY 2025

EPS (Diluted)

-$2.11

FY 2025

Stock Price

$4.71

+2.5%

2026-03-10

52W Range

$1.54 – $9.75

P/E Ratio

-2.2x

Market Cap

$1.6B

Cash

$35.7M

FY 2025

Total Debt

$53.5M

FY 2025

Net Debt

$17.8M

FY 2025

Enterprise Value

$1.6B

Debt / EBITDA

-0.0x

FY 2025

EV / EBITDA

-2.8x

Employees

—